Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety

INTRODUCTION: One of the major challenges in the clinical translation of nanoparticles is the development of formulations combining favorable efficacy and optimal safety. In the past, iron oxide nanoparticles have been introduced as an alternative for gadolinium-containing contrast agents; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Unterweger, Harald, Janko, Christina, Folk, Tamara, Cicha, Iwona, Kovács, Noémi, Gyebnár, Gyula, Horváth, Ildikó, Máthé, Domokos, Zheng, Kang H, Coolen, Bram F, Stroes, Erik, Szebeni, János, Alexiou, Christoph, Dézsi, László, Lyer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128873/
https://www.ncbi.nlm.nih.gov/pubmed/37113796
http://dx.doi.org/10.2147/IJN.S402320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128873/
https://www.ncbi.nlm.nih.gov/pubmed/37113796
http://dx.doi.org/10.2147/IJN.S402320

Ejemplares similares